With R&D and manufacturing in Germany, we develop next-generation therapies that enhance patient outcomes through cutting-edge delivery systems like sublingual films and transdermal patches.
Focused on conditions such as multiple sclerosis and myasthenia gravis, our mission is to transform treatment options and improve quality of life for patients globally. Join us in shaping the future of patient-centered care.
We innovate drug delivery technologiesfor faster, more effective neurodegenerative treatments. Our expertise in thin-film (ODF) formulations brings safer, more accessible therapies to market, pushing the boundaries of science and patient care.
Innovation
Harnessing the most promising advancements in bioscience and pharmaceuticals and the leaders driving change.
Acceleration
Building development capabilities to amplify innovations and increase efficiency, effectiveness and accessibility.
Commercialization
Increasing manufacturing capabilities to scale production and get our products in the hands of those who need them.
Get access to our investor package, corportate presentation & more.
CSE:XPHY FSE:BXT OTCQB:BNXTF
Visit our investors section to get more information. You’ll get a snapshot of our numbers, learn more about what we do & how we’re striving for impact.
Our network of experts and organizations make the difference
Our partnerships include leaders working at the cutting edge of pharmaceutical research and development to drive innovation and disrupt traditional approaches to global health.
Learn more about Bionxt’s innovation to impact strategy and get access to Bionxt investor information.
CSE:BNXT FSE:BXT OTCQB:BNXTF